[Comparison of two conditioning regimens in treatment of leukemia by allogeneic hematopoietic stem cell transplantation]
- PMID: 12948413
[Comparison of two conditioning regimens in treatment of leukemia by allogeneic hematopoietic stem cell transplantation]
Abstract
Background & objective: The conditioning regimens are the critical factors in the allogeneic hematopoietic stem cell transplantation. This study was conducted to compare the effectiveness and side-effects of two conditioning regimens in allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Methods: Twenty-one cases received busulfan(BU) 16 mg/kg plus cyclophosphamide(CY) 120 mg/kg,the other 23 cases received total body irradiation(TBI) 7.5-8.5 Gy plus CY 120 mg/kg regimen.
Results: The 3-year disease-free survivals (DFS) were 61.5% in BU/CY group and 64.7% in TBI/CY group, respectively (P >0.05). The relapse rates were 23.8% and 26%, respectively, without significant difference (P >0.05). The incidence of liver damage in the BU/CY group was higher (80.9%) than that in the TBI/CY group (54.3%) (P< 0.05), while no case developed hepatic veno-occlusive disease. Stomatitis and gastrointestinal toxicity were significantly lower in the BU/CY group (33.3% and 42.9%) compared with TBI/CY group (78.2% and 78.2%), respectively (P< 0.05). Bladder toxicity (23.8% and 26%) and pulmonary toxicity(14.3% and 13%) were similar in the two groups(P >0.05), while one patient in TBI/CY group developed grade IV pulmonary toxicity, which is lethal. No case was found to have cardiac, renal, or central nervous system grade I toxicity.
Conclusion: The two groups have equal effectiveness, BU/CY regimen is relatively easy to administer and well tolerated with low extramedullary toxicity.
Similar articles
-
Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients.Bone Marrow Transplant. 2001 Feb;27(4):349-54. doi: 10.1038/sj.bmt.1702802. Bone Marrow Transplant. 2001. PMID: 11313663 Clinical Trial.
-
[Efficacy and toxicity of intravenous busulfan-based conditioning before allogeneic peripheral blood stem cell transplantation for leukemia].Ai Zheng. 2007 Aug;26(8):914-8. Ai Zheng. 2007. PMID: 17697559 Chinese.
-
Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.J Clin Oncol. 2013 Oct 1;31(28):3549-56. doi: 10.1200/JCO.2013.48.8114. Epub 2013 Aug 26. J Clin Oncol. 2013. PMID: 23980086
-
Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2).Semin Oncol. 1993 Aug;20(4 Suppl 4):33-8; quiz 39. Semin Oncol. 1993. PMID: 8342074 Review.
-
New preparative regimens with diaziquone or cytarabine in combination with busulfan and cyclophosphamide.Semin Oncol. 1993 Aug;20(4 Suppl 4):56-63; quiz 64. Semin Oncol. 1993. PMID: 8342077 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical